Target intelligence / Profile preview

Hepatocyte canalicular membrane transport systems and associated enzymes

Molecular classification
Transporter, Enzyme
01

Overview

The hepatocyte canalicular membrane transport systems and associated enzymes constitute the primary machinery for bile formation and the biliary excretion of metabolites and xenobiotics (PubMed: 24551055). This complex system is localized to the apical membrane of hepatocytes and includes several key ATP-binding cassette (ABC) transporters such as the Bile Salt Export Pump (BSEP/ABCB11), Multidrug Resistance-associated Protein 2 (MRP2/ABCC2), and Multidrug Resistance Protein 3 (MDR3/ABCB4) (UniProt: O95342, Q92887, P21439). These transporters facilitate the active movement of bile salts, conjugated bilirubin, and phospholipids into the bile canaliculi, creating the osmotic gradient necessary for bile flow (PubMed: 10510457). Associated enzymes, such as alkaline phosphatase (ALP) and gamma-glutamyl transferase (GGT), are also anchored to this membrane and serve as clinical markers of canalicular integrity (StatPearls: Physiology, Bile). Impairment of these transport systems, either through genetic defects or inhibition by drugs like cyclosporine or bosentan, can lead to intrahepatic cholestasis and severe liver damage (PubMed: 25241738). Understanding these systems is vital for predicting drug-induced liver injury (DILI) and managing cholestatic diseases.

Other names
Canalicular transportersApical hepatocyte transportersBile secretory apparatusHepatobiliary transport systemCanalicular membrane proteins
02

Mechanism of action

Inhibition of apical efflux transporters (e.g., BSEP), induction of transporter expression via nuclear receptors (e.g., PXR), and competitive substrate binding for biliary excretion

03

Biological functions

Bile secretionXenobiotic transportLipid homeostasisDetoxificationBilirubin clearance
04

Disease associations

CholestasisDrug-induced liver injuryJaundiceGallstonesProgressive familial intrahepatic cholestasisDubin-Johnson syndrome
05

Safety considerations

Drug-induced liver injury (DILI)HyperbilirubinemiaCholestatic pruritusDrug-drug interactionsBile acid malabsorption
06

Interacting drugs

Rifampicin

5 more in the full profile.

07

Biomarkers

Total bilirubinConjugated bilirubinAlkaline phosphatase (ALP)Gamma-glutamyl transferase (GGT)Serum bile acidsLipoprotein X

Beyond the preview

Go deeper on Hepatocyte canalicular membrane transport systems and associated enzymes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Hepatocyte canalicular membrane transport systems and associated enzymes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call